IHC Primary Antibodies
Spanning 14 Pathology menus, Leica Biosystems offers laboratories a comprehensive range of high-quality antibodies for the most demanding workload.
Leica Biosystems talks with Indivumed, a global oncology company. Listen in and watch how these innovative researchers pave the way to their next breakthrough.
“We wanted to implement the latest multiplex IHC technologies on a fully automated staining platform to meet the needs of our customers... The field of immuno-oncology is increasingly moving in this direction in recent years. The BOND RX staining platform and the fluorescent multiplex technologies developed for it were the optimal solution to move in the same direction with our services,” said Dr. Malik Khenkhar, Senior Director IHC Development, Indivumed Group
With the BOND RX stainer you can preserve the morphology and integrity of precious tissue with the unique Covertile system dispenses reagents in a highly-controlled and more consistent manner. 91% of customers find the stain quality and reproducibility to be better than the competition.
The BOND RX system lets researchers fully automate emerging technologies (including new molecular applications), customize all protocol segments, and put theories into action.
Use the BOND RX stainerto confidently complete IHC, ISH, FISH, CTC, multiplexing, and other tests.
Use BOND plug-and-play reagents or optimize your own.
Access the Novocastra antibody range across 14 pathology menus and discover a range of advanced performance Kreatech FISH probes with REPEAT-FREE technology.
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES.
BOND is a trademark of Leica Biosystems and its affiliates.